![EFE: Teràpia gènica per a la síndrome de Sanfilippo B](/Imatge/870/852/cbategwebp,0.gif)
ESTEVE and UAB expand their research to two new gene therapies
They create a promising platform of gene therapy projects with the addition of two new therapies for Sanfilippo B (EGT-201) and Hunter syndromes (EGT-301), designated as orphan drug by the EMA and the FDA.